Keyword Index

Browse for an article via relevant keywords across our entire electronic archive

Search results for: M
Results 71 - 80 of 606 shown below

  • management LSIL

    C Scheungraber, N Kleekamp and A Schneider

    Management of low-grade squamous intraepithelial lesions of the uterine cervix

    doi:10.1038/sj.bjc.6601415

  • manganese

    Y Takehara, H Sakahara, H Masunaga, S Isogai, N Kodaira, H Takeda, T Saga, S Nakajima and I Sakata

    Tumour enhancement with newly developed Mn-metalloporphyrin (HOP-9P) in magnetic resonance imaging of mice

    doi:10.1054/bjoc.2001.1802

  • manganese superoxide dismutase

    K Kahlos, P Pääkkö, E Kurttila, Y Soini and V L Kinnula

    Manganese superoxide dismutase as a diagnostic marker for malignant pleural mesothelioma

    doi:10.1054/bjoc.1999.1037

  • mannose 6-phosphate/insulin-like growth factor-2 receptor

    N Sedlaczek, A Hasilik, P Neuhaus, D Schuppan and H Herbst

    Focal overexpression of insulin-like growth factor 2 by hepatocytes and cholangiocytes in viral liver cirrhosis

    doi:10.1038/sj.bjc.6600777

  • mantle cell lymphoma (MCL)

    C Schrader, D Janssen, W Klapper, J-U Siebmann, P Meusers, G Brittinger, M Kneba, M Tiemann and R Parwaresch

    Minichromosome maintenance protein 6, a proliferation marker superior to Ki-67 and independent predictor of survival in patients with mantle cell lymphoma

    advance online publication, 2005-09-27 00:00:00.000;

    doi:10.1038/sj.bjc.6602795

  • Mantova

    V Ascoli, S Belli, M Benedetti, S Trinca, P Ricci and P Comba

    High incidence of classic Kaposi's sarcoma in Mantua, Po Valley, Northern Italy (1989-1998)

    doi:10.1054/bjoc.2001.1912

  • manumycin

    A Di Paolo, R Danesi, D Nardini, G Bocci, F Innocenti, S Fogli, S Barachini, A Marchetti and G Bevilacqua

    Manumycin inhibits ras signal transduction pathway and induces apoptosis in COLO320-DM human colon tumourcells

    doi:10.1054/bjoc.1999.1018

  • MAP kinase

    X Gu, J Niu, D J Dorahy, R Scott and M V Agrez

    Integrin alphavbeta6-associated ERK2 mediates MMP-9 secretion in colon cancer cells

    doi:10.1038/sj.bjc.6600480

  • L McMillan, S K Butcher, J Pongracz and J M Lord

    Opposing effects of butyrate and bile acids on apoptosis of human colon adenoma cells: differential activation of PKC and MAP kinases

    doi:10.1038/sj.bjc.6600793

  • K S M Smalley, R Contractor, N K Haass, J T Lee, K L Nathanson, C A Medina, K T Flaherty and M Herlyn

    Ki67 expression levels are a better marker of reduced melanoma growth following MEK inhibitor treatment than phospho-ERK levels

    advance online publication, 2007-01-23 00:00:00.000;

    doi:10.1038/sj.bjc.6603596

  • P A Havre, M Abe, Y Urasaki, K Ohnuma, C Morimoto and N H Dang

    CD26 expression on T cell lines increases SDF-1-alpha-mediated invasion

    advance online publication, 2009-08-04 00:00:00.000;

    doi:10.1038/sj.bjc.6605236

  • Y Ueoka, K Kato, Y Kuriaki, S Horiuchi, Y Terao, J Nishida, H Ueno and N Wake

    Hepatocyte growth factor modulates motility and invasiveness of ovarian carcinomas via Ras-mediated pathway

    doi:10.1054/bjoc.1999.1016

  • S Ding, M Chamberlain, A McLaren, L-b Goh, I Duncan and C R Wolf

    Cross-talk between signalling pathways and the multidrug resistant protein MDR-1

    doi:10.1054/bjoc.2001.2044

  • X M Liu, L G Wang, W Kreis, D R Budman and L M Adams

    Differential effect of vinorelbine versus paclitaxel on ERK2 kinase activity during apoptosis in MCF-7 cells

    doi:10.1054/bjoc.2001.2107

  • MAPK

    N Magné, J L Fischel, A Dubreuil, P Formento, M-F Poupon, P Laurent-Puig and G Milano

    Influence of epidermal growth factor receptor (EGFR), p53 and intrinsic MAP kinase pathway status of tumour cells on the antiproliferative effect of ZD1839 ('Iressa')

    doi:10.1038/sj.bjc.6600299

  • W Jin, L Wu, K Liang, B Liu, Y Lu and Z Fan

    Roles of the PI-3K and MEK pathways in Ras-mediated chemoresistance in breast cancer cells

    doi:10.1038/sj.bjc.6601048

  • E O'Neill and W Kolch

    Conferring specificity on the ubiquitous Raf/MEK signalling pathway

    doi:10.1038/sj.bjc.6601488

  • S Vicent, J M López-Picazo, G Toledo, M D Lozano, W Torre, C Garcia-Corchón, C Quero, J-C Soria, S Martín-Algarra, R G Manzano and L M Montuenga

    ERK1/2 is activated in non-small-cell lung cancer and associated with advanced tumours

    doi:10.1038/sj.bjc.6601644

  • M Aubele, A K Walch, N Ludyga, H Braselmann, M J Atkinson, B Luber, G Auer, S Tapio, T Cooke and J M S Bartlett

    Prognostic value of protein tyrosine kinase 6 (PTK6) for long-term survival of breast cancer patients

    advance online publication, 2008-09-09 00:00:00.000;

    doi:10.1038/sj.bjc.6604660

  • R K Singh, T S Lange, K K Kim, A P Singh, N Vorsa and L Brard

    Isothiocyanate NB7M causes selective cytotoxicity, pro-apoptotic signalling and cell-cycle regression in ovarian cancer cells

    advance online publication, 2008-11-11 00:00:00.000;

    doi:10.1038/sj.bjc.6604778

  • C Simon, M J Hicks, A J Nemechek, R Mehta, B W O'Malley Jr, H Goepfert, C M Flaitz and D Boyd

    PD 098059, an inhibitor of ERK1 activation, attenuates the in vivo invasiveness of head and neck squamous cell carcinoma

    doi:10.1038/sj.bjc.6690537

  • A Budillon, E Di Gennaro, M Caraglia, D Barbarulo, A Abbruzzese and P Tagliaferri

    8-Cl-cAMP antagonizes mitogen-activated protein kinase activation and cell growth stimulation induced by epidermal growth factor

    doi:10.1038/sj.bjc.6690820

  • J Ostrowski, M Woszczynski, P Kowalczyk, T Wocial, E Hennig, L Trzeciak, P Janik and K Bomsztyk

    Increased activity of MAP, p70S6 and p90rs kinases is associated with AP-1 activation in spontaneous liver tumours, but not in adjacent tissue in mice

    doi:10.1054/bjoc.1999.1040

  • B Liu, M Fang, Y Lu, Y Lu, G B Mills and Z Fan

    Involvement of JNK-mediated pathway in EGF-mediated protection against paclitaxel-induced apoptosis in SiHa human cervical cancer cells

    doi:10.1054/bjoc.2001.1910

  • MAPK AP-1

    L O Murphy, M W Cluck, S Lovas, F Ötvös, R F Murphy, A V Schally, J Permert, J Larsson, J A Knezetic and T E Adrian

    Pancreatic cancer cells require an EGF receptor-mediated autocrine pathway for proliferation in serum-free conditions

    doi:10.1054/bjoc.2001.1698